HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Ri Kim Selected Research

R-CHOP protocol

1/2020Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
11/2017Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
4/2015Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Ri Kim Research Topics

Disease

9Ischemic Stroke
01/2022 - 01/2014
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2021 - 08/2012
8Neoplasms (Cancer)
01/2021 - 01/2008
7Lymphoma (Lymphomas)
09/2020 - 08/2012
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 12/2013
4Stroke (Strokes)
01/2022 - 01/2014
4Melanoma (Melanoma, Malignant)
10/2018 - 10/2011
4Brain Ischemia (Cerebral Ischemia)
07/2016 - 12/2013
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2022 - 08/2011
3Ischemia
01/2022 - 01/2014
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2020 - 11/2010
3Neuroinflammatory Diseases
01/2020 - 01/2018
3Neoplasm Metastasis (Metastasis)
10/2018 - 01/2012
3Leukemia
02/2015 - 10/2008
2POEMS Syndrome (Syndrome, POEMS)
04/2022 - 11/2014
2Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 01/2021
2Headache (Headaches)
02/2022 - 06/2014
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2016
2Brain Diseases (Brain Disorder)
01/2020 - 01/2014
2Memory Disorders (Memory Loss)
05/2019 - 01/2018
2Erythema
02/2018 - 12/2014
2Infarction (Infarctions)
07/2016 - 01/2014
2Seborrheic Dermatitis
05/2016 - 12/2014
2Burkitt Lymphoma (Burkitt's Lymphoma)
04/2016 - 04/2015
2Pain (Aches)
06/2014 - 02/2012
1Sleep Wake Disorders
02/2022
1Fatigue
02/2022
1Multiple Myeloma
01/2022
1Febrile Neutropenia
09/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2021
1Neutropenia
09/2021
1Fever (Fevers)
09/2021
1Sepsis (Septicemia)
04/2021
1Thyroid Neoplasms (Thyroid Cancer)
01/2021
1Anemia
01/2021
1Heart Failure
01/2021
1Body Weight (Weight, Body)
01/2020
1Purpura
02/2018

Drug/Important Bio-Agent (IBA)

5Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019 - 01/2014
4Neuroprotective AgentsIBA
01/2019 - 01/2014
4Rituximab (Mabthera)FDA Link
11/2017 - 08/2012
3CytokinesIBA
04/2022 - 01/2013
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2010
3Ferritins (Ferritin)IBA
01/2022 - 01/2008
3Antidepressive Agents (Antidepressants)IBA
01/2020 - 02/2017
3R-CHOP protocolIBA
01/2020 - 04/2015
3Proteins (Proteins, Gene)FDA Link
10/2018 - 10/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 01/2014
2omega-Chloroacetophenone (Mace)IBA
02/2022 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2022 - 02/2014
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2017
2Scopolamine (Hyoscine)FDA Link
05/2019 - 01/2018
2AcetylcholinesteraseIBA
05/2019 - 06/2004
2Small Interfering RNA (siRNA)IBA
10/2018 - 11/2010
2Cilostazol (Pletal)FDA LinkGeneric
02/2017 - 03/2016
2Aripiprazole (Abilify)FDA Link
02/2017 - 01/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2016 - 06/2015
2Methotrexate (Mexate)FDA LinkGeneric
01/2016 - 02/2014
2Vincristine (Oncovin)FDA LinkGeneric
04/2015 - 02/2014
2C-Reactive ProteinIBA
11/2014 - 01/2012
2AlbuminsIBA
11/2014 - 01/2012
2Melanins (Melanin)IBA
05/2012 - 10/2011
2Monophenol Monooxygenase (Tyrosinase)IBA
05/2012 - 10/2011
1Lenalidomide (CC 5013)FDA Link
04/2022
1Bortezomib (Velcade)FDA Link
04/2022
1Thalidomide (Thalomid)FDA Link
04/2022
1Biomarkers (Surrogate Marker)IBA
04/2022
1Pharmaceutical Sleep AidsIBA
02/2022
1saponarinIBA
02/2022
1AntioxidantsIBA
01/2022
1OsteopontinIBA
01/2022
1Small Cytoplasmic RNAIBA
01/2022
1EnzymesIBA
01/2022
1LenograstimIBA
09/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2021
1IodineIBA
01/2021
1Histone MethyltransferasesIBA
04/2020
1TESIBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1Reserpine (Serpasil)FDA Link
01/2020
1Acetylcholine (Acetylcholine Chloride)FDA Link
05/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1TropomyosinIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1CorticosteroneIBA
01/2018
1ChitinasesIBA
01/2018
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2018

Therapy/Procedure

10Drug Therapy (Chemotherapy)
09/2021 - 08/2011
6Therapeutics
01/2021 - 09/2012
6Electroacupuncture
01/2019 - 02/2012
5Hematopoietic Stem Cell Transplantation
09/2020 - 01/2008
3Acupuncture Points (Acupuncture Point)
01/2018 - 01/2014
3Stem Cell Transplantation
09/2016 - 01/2008
2Radiotherapy
01/2021 - 11/2014
2Lasers (Laser)
02/2018 - 03/2017
2Transplantation
09/2012 - 01/2008
1Percutaneous Coronary Intervention
01/2021
1Transcranial Direct Current Stimulation
01/2020